It is without a doubt an honor and privilege as your Editor in Chief of CannaHealthcare Magazine to present you our first publication, already capturing an International audience with over 54,000 subscribers prior to our launch, validating the intrigue and interest in our approach to the Science of Cannabis. Our approach is one from the Clinical & Patient perspective dedicated those in the Clinical ecosystem.
CannaHealthcare Magazine offers the ONLY online multidisciplinary approach to Medical Cannabis, and I have all the confidence CannaHealthcare Magazine will become one of the premier publications of choice for Medical Professionals Internationally seeking integral and tangible research.
As a Corporate Executive in Biotechnology focused on Neuro Research, I can tell you the Education, and the Science matter, and the most important thing we can do is conduct further research, while in the interim acknowledging the promise Cannabis has demonstrated in past and present studies. Research is only research if we continue to examine and evaluate what has already shown to impact diverse indications with great efficacy. We must pursue the momentum in research to determine further therapeutic value(s), and to ignore further research in Cannabis would be nothing short of negligent.
We know healthcare Providers are challenged with what to offer Patients after having exhausted all treatments and medications that have not mitigated many chronic medical problems. Cannabis has quickly become the Alternative choice for many patients.
Patients have become the Researcher on the Internet highway of information, searching out Alternative pathways to healing and discovering Medical Vacations utilizing Cannabis, whereby they accessing more affordable alternatives or Progressive Clinical Studies in other countries.
As Medical Cannabis expands into the Global merging market, the promotion of further research is critical to stay engaged with Patients participating in the promotion of new clinical discoveries that have the potential to impact future generations in health.
My objectives for our publication seem best summarized as follows:
- To maintain the highest standards of editorial integrity
- To publish original, important, valid, peer-reviewed articles on a diverse range of medical
topics as it relates to Medical Cannabis.
- To enable physicians to remain informed in multiple areas of Cannabis medicine, including
developments.
- To improve health and health care internationally by elevating the quality of medical care,
disease prevention, and research
- To inform readers about the various aspects of medicine and public health, including the
political, philosophic, ethical, legal, environmental, economic, historical, and cultural
- To achieve the highest level of ethical medical journalism and to produce a publication that
is timely, credible, and enjoyable but educational as well.
Together we can make a difference in our journey through the Science, and it begins when we choose to join the Clinical conversation without prejudice, but basing our research not on opinion but on science, this is how we positively impact health and wellness as a collaborative approach to the education and awareness as it relates to Medical Cannabis.
If you are interested in sharing an article or abstract you have published as it relates to Medical Cannabis, please send to my email below for consideration.
I thank you in advance for your time, and look forward to every issue we bring to you, always seeking to over deliver in our content and value.
Yours in health,
Amy
From the Editor in Chief:
Amy Berliner is the Founder/CEO or Aegis Biotech
& Editor-in-Chief of CannaHealthcare Magazine
4